Since 2004, Innovative Diagnostics (ID) develops, produces and sells ELISA, PCR and rapid tests for the clinical and animal health sectors. Located near Montpellier, France, 120
employees work in our vast 4000 m² laboratory facilities. ID is an actor of the One Health approach, which recognizes that human health and animal health are interdependent. We help to protect both human health and the global food supply by offering diagnostic tests to detect zoonotic diseases in humans and animals, and veterinary diseases in farm animals. Our tests for zoonotic diseases include COVID-19, Rift Valley Fever, West Nile Fever, Q Fever, Crimea Congo Haemorrhagic Fever, and Bovine Tuberculosis. Our reknown IDvet product line covers major veterinary diseases, which have a significant impact on the food supply in recent years include Foot and Mouth Disease and African Swine Fever. ID is independent and 100% self-financed with its own R&D activities and state-of-the art, automated production line, allowing the company to react immediately to sanitary emergencies. ID is a rapidly growing company with sales covering over 100 countries with offices in Brazil, India and China, and a starting production facility in the USA.
Since 2016 ID is committed in spin-off activities. ID is one of the founder and main shareholder of ID Solutions who is one of the major player in COVID PCR kits production in France. ID supports ADELIS which develops an breakthrough technology for circulating DNA. ID invested in some of the more promising companies of the “MED Valley” of Montpellier.